Advertisement

Almac Clinical Services Launches Virtual Auditing Solution for Clients

almac clinical services launches virtual auditing solution for clients

BEGIN ARTICLE PREVIEW:

CRAIGAVON, Northern Ireland, Aug. 11, 2020 /PRNewswire/ — Almac Clinical Services has digitised its conventional on-site auditing process and launched a virtual auditing solution for clients. This is to ensure continued quality and regulatory compliance during the current COVID-19 pandemic, maintain GMP standards and deliver on the terms of quality and technical agreements all whilst protecting employees and upholding social corporate responsibility to partners and suppliers. Global clients can realise clear advantages, saving time and money otherwise spent on travel and accommodation requirements.
Within the clinical supply industry, there is a significant emphasis on robust supply chain processes. Audits are essential and play a critical role in ensuring clients can continue to deliver and meet regulatory standards. With continued advances in technologies available for business communication and as a direct response to travel restrictions and social distancing measures posed by the current pandemic, postponing audits is not a long-term option. Almac is, therefore, offering a series of alternative auditing strategies for its clients, enabling them to facilitate ongoing clinical trials and accelerate timelines for COVID-19 studies. 
“With a changing clinical trial landscape and the need for an adaptable business model due to impacts of COVID-19, Almac continues to innovate and provide solutions …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE

Worldwide Medical Ventilators Industry to 2024 – Impact of the COVID-19 Pandemic

worldwide medical ventilators industry to 2024 – impact of the covid-19 pandemic

BEGIN ARTICLE PREVIEW:

DUBLIN, Aug. 11, 2020 /PRNewswire/ — The “Global Medical Ventilators Market” report has been added to ResearchAndMarkets.com’s offering.
This report examines the current and future market potential of medical ventilators. It offers a detailed analysis of the competitive environment, regulatory scenario, technological advancement, drivers and restraints, and opportunity and trends in market growth. The report also covers market projections to 2024 and market rank for key market players. The report details the market share of medical ventilators based on types of ventilation, types of products, and end-users.
This report segments the global market by these geographical regions: North America, Europe, Asia-Pacific, and the Rest of the world. The North America region includes the U.S., Canada, and Mexico; the European region includes Germany, the U.K., France, and the Rest of Europe; the Asia-Pacific region includes China, India, Japan, Rest of Asia-Pacific. For market estimates, data is provided for the year 2018 as the base year, 2019, and forecast through year-end 2024.
The Report Includes:

46 data tables and 16 additional tables
An overview of the global market for medical ventilators within the industry
Analyses of the global market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
Regional analysis, market potential …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Worldwide Medical Ventilators Industry to 2024 – Impact of the COVID-19 Pandemic”

Thentia Closes Series A With BDC to Bring Advanced Tech to Regulation

thentia closes series a with bdc to bring advanced tech to regulation

BEGIN ARTICLE PREVIEW:

Thentia Closes Series A With BDC to Bring Advanced Tech to Regulation



We store cookies on your computer to improve your experience and provide more personalized services, both on this website and on other sites. For more information about the cookies we use, see our Privacy Policy. We won’t track your information when you visit our site. We will have to use at least one cookie to ensure that you won’t have to make this choice again.AcceptDeclinePrivacy Policy

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Thentia Closes Series A With BDC to Bring Advanced Tech to Regulation”

Wolters Kluwer and Chartis to host regulatory data webinar

iam platform login page background

BEGIN ARTICLE PREVIEW:

Wolters Kluwer’s Finance, Risk & Reporting (FRR) business is hosting a webinar dedicated to discussing how banks should be encouraged to adopt a strategic approach to align regulatory and financial data. The event, taking place on August 26, is being co-hosted with Chartis Research and will include tips for how banks can best deal with the spiraling data management costs resulting from disruptions caused by the COVID-19 pandemic.A strategic approach for aligning regulatory and financial data improves operational efficiencies leading to better business decisions. Topics up for discussion include exploring how universal data from accounting standards like IFRS9 and CECL can be leveraged for a consistent approach to data across an enterprise and best practices for ensuring proper data management.Speakers at the event include Will Newcomer, Vice President of Strategy for Wolters Kluwer FRR, Americas, and Sidharth Dash, Research Director for Chartis.Wolters Kluwer FRR, which is part of Wolters Kluwer’s Governance, Risk & Compliance division, is a global market leader in the provision of integrated regulatory compliance and reporting solutions. It supports regulated financial institutions in meeting their obligations to external regulators and their own board of directors.Wolters Kluwer FRR receives frequent independent recognition of its excellence …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Wolters Kluwer and Chartis to host regulatory data webinar”

Pulse Biosciences, Inc. (PLSE) Q2 2020 Earnings Call Transcript @themotleyfool #stocks $PLSE

pulse biosciences, inc. (plse) q2 2020 earnings call transcript @themotleyfool #stocks $plse

BEGIN ARTICLE PREVIEW:

Image source: The Motley Fool.

Pulse Biosciences, Inc. (NASDAQ:PLSE)Q2 2020 Earnings CallAug 10, 2020, 4:30 p.m. ETContents:

Prepared Remarks
Questions and Answers
Call Participants

Prepared Remarks:
OperatorThank you for standing by. This is the conference operator. Welcome to the Pulse Biosciences Second Quarter 2020 Earnings Conference Call. [Operator Instructions]I would now like to turn the conference over to Philip Taylor, Investor Relations. Please go ahead.Philip Taylor — Investor RelationsThank you, operator. Before we begin, I would like to inform you that comments and responses to your questions during today’s call reflect management’s views as of today, August 10, 2020, only and will include forward-looking statements and opinion statements. These include statements regarding our plans and expectations relating to regulatory clearance, including the process, time lines and expected outcomes; our commercial, operational, scientific, clinical and financial projection; products, including the uses benefits and applications of such products; our commercial and regulatory strategies; the impact of the COVID-19 pandemic and other future events.Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our most recent Form 10-Q filed May 11, 2020 with the SEC. Our SEC filings can …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Pulse Biosciences, Inc. (PLSE) Q2 2020 Earnings Call Transcript @themotleyfool #stocks $PLSE”

Public Notices/Calendars | The Legal Intelligencer

public notices/calendars | the legal intelligencer

BEGIN ARTICLE PREVIEW:

Premium Subscription
With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
View Now

Team Accounts
Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
View Now

Bundle Subscriptions
Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
View Now

CLE Center →

From Data to Decisions
Dynamically explore and compare data on law firms, companies, individual lawyers, and industry trends.

Exclusive Depth and Reach.
Legal Compass includes access to our exclusive industry reports, combining the …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Public Notices/Calendars | The Legal Intelligencer”

Regeneus Ltd (ASX:RGS) and Kyocera Sign Progenza OA Deal

regeneus ltd (asx:rgs) and kyocera sign progenza oa deal

BEGIN ARTICLE PREVIEW:

Sydney, Australia, Aug 11, 2020 – (ABN Newswire) – Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced that Kyocera Corporation (Kyocera, TYO:6971) has signed a licence agreement to develop and commercialise Progenza for Knee Osteoarthritis (Progenza OA) in Japan. Highlights: – Regeneus and Kyocera have signed a licence and collaboration agreement for Kyocera to exclusively develop and commercialise Regeneus’ lead stem cell platform technology Progenza for the treatment of Knee Osteoarthritis (Knee OA) in Japan – Regeneus to receive US$19m (A$27m) in upfront, development and regulatory milestone payments – Additional single to high double-digit royalties on Progenza OA product sales in Japan based on future reimbursement prices – Kyocera will fund manufacturing, development, and commercialisation costs for Progenza OA in Japan under the agreement – Upfront payment provides cash runway for Regeneus through to the commercial launch of Progenza OA in Japan o The global market for osteoarthritis is expected to grow to US$3.5 billion by 2026 with the Japanese market worth US$350 million. The potential osteoarthritis patient population is 25.6 million in Japan with 1.25 million people receiving treatment, and is expected to rise each year. Progenza OA has already completed a Phase I study which met all safety …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Regeneus Ltd (ASX:RGS) and Kyocera Sign Progenza OA Deal”

Three Crypto Analysis Firms Advance in ‘TechSprint’ RegTech Competition – CoinDesk

three crypto analysis firms advance in ‘techsprint’ regtech competition – coindesk

BEGIN ARTICLE PREVIEW:

Three blockchain analysis firms are among the companies shortlisted in the “TechSprint” regulatory technology hackathon co-sponsored by the Bank for International Settlements (BIS) Innovation Hub and the Saudi G20 Presidency.
DisclosureThe leader in blockchain news, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups.

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Three Crypto Analysis Firms Advance in ‘TechSprint’ RegTech Competition – CoinDesk”